Systemic GDF11 replenishment ignites myocardial injury through diminishing anti-apoptotic activity of cardiac progenitor cells

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Simon Kraler

Bern University Hospital, Inselspital, Bern (Switzerland)

4 More presentations in this session

Presentation thumbnail

FYCO1 ameliorates adverse cardiac remodeling in response to myocardial ischemia by enhancing autophagic flux

Miss F. Senger (Heidelberg, DE)

Abstract Slides Video

Presentation thumbnail

Impaired Cardioprotection by HDL in CAD and Diabetes in Ischemia/Reperfusion Injury: role of S1P and SR-BI

Doctor A. Polzin (Duesseldorf, DE)

Abstract Slides Video

Presentation thumbnail

Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

Doctor P. Nikolaou (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection via the purinergic P2Y13 receptor and nitric oxide signalling

Doctor T. JIAO (Stockholm, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Myocardial ischaemia and protective mechanisms

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Circulating growth differentiation factor 11 exacerbates myocardial injury in mice and associates with increased infarct size in humans

Congress Presentation

RNA therapies for cardiac regeneration

Congress Presentation

GDF-15 is associated with worse ischemic and bleeding outcomes in the acute phase and during follow-up in patients with acute coronary syndrome: insights from the TRACER trial

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources